Evaluation the safety and effectiveness of Oxiplex Gel for reduction of pain and associated symptoms followingsingle level lumbar discectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N106

Enrollment

Registered

2019-04-23

Start date

2018-06-22

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc. Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder

Interventions

Intervention 1: Intervention group:?First group receive Oxiplex gel are placed right in the site before closure of the surgical site. Intervention 2: Control group:Second group receive placebo are

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 18-70 years Lumbar disc disease

Exclusion criteria

Exclusion criteria: Dissatisfaction

Design outcomes

Primary

Measure	Time frame
Disability. Timepoint: Before intervention, 1, 3 and 6 months after intervention. Method of measurement: Oswestry low back pain disability.;Pain. Timepoint: Before intervention, 1, 3 and 6 months after intervention. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Mohammadi

Arak University of Medical Sciences

mohamadi@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026